{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:09:34Z","timestamp":1792804174121,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejpn-journal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.ejpn.2016.02.003","type":"journal-article","created":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T08:15:45Z","timestamp":1455696945000},"page":"625-629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Medication use in childhood dystonia"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5524-6177","authenticated-orcid":false,"given":"Daniel E.","family":"Lumsden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Kaminska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Tomlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ejpn.2016.02.003_bib1","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/mds.23088","article-title":"Definition and classification of hyperkinetic movements in childhood","volume":"25","author":"Sanger","year":"2010","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.ejpn.2016.02.003_bib2","first-page":"413","article-title":"The varied etiologies of childhood-onset dystonia","volume":"158","author":"Roubertie","year":"2002","journal-title":"Rev Neurol Paris"},{"issue":"11","key":"10.1016\/j.ejpn.2016.02.003_bib3","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1136\/jnnp-2013-307041","article-title":"The impact and prognosis for dystonia in childhood including dystonic cerebral palsy: a clinical and demographic tertiary cohort study","volume":"85","author":"Lin","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/j.ejpn.2016.02.003_bib4","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1468-1331.2011.03649.x","article-title":"Treatment for dystonia in childhood","volume":"19","author":"Roubertie","year":"2012","journal-title":"Eur J Neurol"},{"issue":"7","key":"10.1016\/j.ejpn.2016.02.003_bib5","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/mds.25548","article-title":"Special concerns in defining, studying, and treating dystonia in children","volume":"28","author":"Mink","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.ejpn.2016.02.003_bib6","first-page":"101","article-title":"Dystonia genotypes, phenotypes, and classification","volume":"94","author":"Bressman","year":"2004","journal-title":"Adv Neurol"},{"issue":"2","key":"10.1016\/j.ejpn.2016.02.003_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejpn.2012.07.007","article-title":"Functional priorities in daily life for children and young people with dystonic movement disorders and their families","volume":"17","author":"Gimeno","year":"2013","journal-title":"Eur J Paediatr Neurol."},{"issue":"6","key":"10.1016\/j.ejpn.2016.02.003_bib8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1468-1331.2004.00845.x","article-title":"Efficacy of pharmacological treatment of dystonia: evidence-based review including meta-analysis of the effect of botulinum toxin and other cure options","volume":"11","author":"Balash","year":"2004","journal-title":"Eur J Neurol"},{"issue":"6","key":"10.1016\/j.ejpn.2016.02.003_bib9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/archdischild-2011-301170","article-title":"An overview of drug therapies used in the treatment of dystonia and spasticity in children","volume":"97","author":"Tickner","year":"2012","journal-title":"Arch Dis Child Educ Pract Ed"},{"issue":"4","key":"10.1016\/j.ejpn.2016.02.003_bib10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1469-8749.1997.tb07414.x","article-title":"Development and reliability of a system to classify gross motor function in children with cerebral palsy","volume":"39","author":"Palisano","year":"1997","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"10.1016\/j.ejpn.2016.02.003_bib11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/mds.870070109","article-title":"Baclofen in the treatment of idiopathic dystonia in children","volume":"7","author":"Greene","year":"1992","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.ejpn.2016.02.003_bib12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00002826-199208000-00002","article-title":"Baclofen in the treatment of dystonia","volume":"15","author":"Greene","year":"1992","journal-title":"Clin Neuropharmacol"},{"issue":"5","key":"10.1016\/j.ejpn.2016.02.003_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/08830738030180050701","article-title":"Natural history of Oppenheim's dystonia (DYT1) in Israel","volume":"18","author":"Anca","year":"2003","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ejpn.2016.02.003_bib14","first-page":"189","article-title":"Double-blind evaluation of trihexyphenidyl in dystonia","volume":"37","author":"Burke","year":"1983","journal-title":"Adv Neurol"},{"issue":"1","key":"10.1016\/j.ejpn.2016.02.003_bib15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0887-8994(01)00287-9","article-title":"Age-dependent effects of trihexyphenidyl in extrapyramidal cerebral palsy","volume":"25","author":"Hoon","year":"2001","journal-title":"Pediatr Neurol"},{"issue":"4","key":"10.1016\/j.ejpn.2016.02.003_bib16","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/mds.23478","article-title":"Levodopa is not a useful treatment for Lesch-Nyhan disease","volume":"26","author":"Visser","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.ejpn.2016.02.003_bib17","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1136\/bmj.e281","article-title":"Diagnosis and management of the epilepsies in adults and children: summary of updated NICE guidance","volume":"344","author":"Nunes","year":"2012","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ejpn.2016.02.003_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1212\/WNL.35.1.73","article-title":"Validity and reliability of a rating scale for the primary torsion dystonias","volume":"35","author":"Burke","year":"1985","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ejpn.2016.02.003_bib19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/dmcn.12965","article-title":"Burke-Fahn-Marsden dystonia severity, gross motor, manual ability and communication function classification scales in childhood hyperkinetic movement disorders including cerebral palsy: a Rosetta Stone study","volume":"58","author":"Elze","year":"2016","journal-title":"Dev Med Child Neurol"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379816000362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379816000362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T23:13:28Z","timestamp":1657408408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379816000362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1090379816000362"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2016.02.003","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication use in childhood dystonia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2016.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}